Literature DB >> 28936007

A Phase 1, Open-Label, Single Dose Pharmacokinetic Study in Stabilized Patients with Schizophrenia Following Risperidone Implant.

Ryan Dammerman1, Sonnie Kim1, Mathews Adera1, Alex Schwarz1.   

Abstract

Entities:  

Keywords:  dose-ranging; pharmacokinetics; risperidone implant; schizophrenia

Year:  2017        PMID： 28936007

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  2 in total

1.  Schizophrenia: overview and treatment options.

Authors:  Krishna R Patel; Jessica Cherian; Kunj Gohil; Dylan Atkinson
Journal:  P T       Date:  2014-09

2.  Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

Authors:  M L Huang; A Van Peer; R Woestenborghs; R De Coster; J Heykants; A A Jansen; Z Zylicz; H W Visscher; J H Jonkman
Journal:  Clin Pharmacol Ther       Date:  1993-09       Impact factor: 6.875
  2 in total
  1 in total

1.  Long-acting implants to treat and prevent HIV infection.

Authors:  Ethel D Weld; Charles Flexner
Journal:  Curr Opin HIV AIDS       Date:  2020-01       Impact factor: 4.061
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.